Shares in Glenmark Pharmaceuticals Ltd. were under pressure on Indian bourses after its manufacturing site in Baddi, Himachal Pradesh, failed to pass muster in an FDA audit earlier this month.
The GMP setback comes amid a challenging business environment in the US, one of Glenmark’s key markets. Recent pricing pressure...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

